Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04534283
Title A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Anita Turk

Advanced Solid Tumor


Abemaciclib + LY3214996

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST